Biogen shares slump after Samsung Biologics denial of buyout report

biogen-shares-slump-after-samsung-biologics-denial-of-buyout-report

Steven Goldstein is based in London and responsible for MarketWatch’s coverage of financial markets in Europe, with a particular focus on global macro and commodities. Previously, he was Washington bureau chief, directing MarketWatch’s economic, political and regulatory coverage. Follow Steve on Twitter: @MKTWgoldstein.

Source: Marketwatch

Related Posts